Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mercedes, Servigna"'
Autor:
Ana Serrano, Edgardo Carrizo, Gabriela Velez, Mercedes Servigna, Ignacio Sandia, Trino Baptista, Nayibe Rojas, Erika Fernández
Publikováno v:
Gaceta Médica de Caracas. 128:275-279
La clozapina (CLZ) es el fármaco de primera elección en el tratamiento de la esquizofrenia resistente, pero también se usa en la demencia, el trastorno bipolar, la ansiedad severa, el autismo y los trastornos anormales del movimiento, entre muchos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fe3c719b5b3e2b6a807cc6a0de89cd0
https://doi.org/10.47307/gmc.2020.128.3.4
https://doi.org/10.47307/gmc.2020.128.3.4
Autor:
Trino, Baptista, Edgardo, Carrizo, Nayibe, Rojas, Erika, Fernández, Gabriela, Velaz, Mercedes, Servigna, Ana, Serrano, Ignacio, Sandia, José, de Leon, Saberio, Pérez-Lopresti
Publikováno v:
Investigacion clinica. 57(4)
Myocarditis occurs more frequently during clozapine (CLZ) administration than during treatment with other antipsychotic drugs (APs). In this observational study, we transversally screened outpatients for myocarditis by comparing a CLZ group of 132 su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f1c19b6931104b9412428d8a3b52aaa1
https://pubmed.ncbi.nlm.nih.gov/29938983
https://pubmed.ncbi.nlm.nih.gov/29938983
Autor:
Mercedes Servigna, Ignacio Sandia, Natacha Pirela, Ana Serrano, Lisette Connell, Jesús Quintero, Albis Pabón, Agner Parra, Euderruh Uzcáteguid, Lisbeth Villarreal, Erika Fernández, Trino Baptista, Edgardo Carrizo
Publikováno v:
Schizophrenia Research. 166:207-211
Constipation occurs in 25-60% of the subjects during administration of the antipsychotic drug (AP) clozapine (CLZ).We used a colonic transit diagnostic test that quantifies in a single abdominal X-ray the number of silver O-ring markers out of 25 uni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a9910268bb778712acc278420302426
https://doi.org/10.1016/j.schres.2015.05.025
https://doi.org/10.1016/j.schres.2015.05.025
Autor:
Mercedes Servigna, Edgardo Carrizo, Euderruh Uzcátegui, Tatiana Galeazzi, Marycelvia Uzcátegui, Nairy Rangel, Ana Serrano, María A. Gutiérrez, Serge Beaulieu, Enma Araujo de Baptista, Lisette Connell, Yamily El Fakih, Virginia Fernández, Trino Baptista, Adriana Dávila
Publikováno v:
Schizophrenia research. 93(1-3)
Background Excessive body weight gain (BWG) is a clinically relevant side effect of olanzapine administration. The primary objective of this study was to assess whether metformin prevents or reverses BWG in patients with schizophrenia or bipolar diso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254fa57625682d6dcb5e2120b9315ec9
https://pubmed.ncbi.nlm.nih.gov/17490862
https://pubmed.ncbi.nlm.nih.gov/17490862